ADC Therapeutics Statistics
Total Valuation
ADCT has a market cap or net worth of $347.62 million. The enterprise value is $533.83 million.
Important Dates
The last earnings date was Tuesday, August 12, 2025, before market open.
| Earnings Date | Aug 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ADCT has 112.50 million shares outstanding. The number of shares has increased by 25.84% in one year.
| Current Share Class | 112.50M |
| Shares Outstanding | 112.50M |
| Shares Change (YoY) | +25.84% |
| Shares Change (QoQ) | +6.10% |
| Owned by Insiders (%) | 3.29% |
| Owned by Institutions (%) | 23.80% |
| Float | 92.19M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4.31 |
| Forward PS | 6.28 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 6.91 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.93
| Current Ratio | 4.93 |
| Quick Ratio | 4.50 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -2.54 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -22.99% |
| Return on Invested Capital (ROIC) | -28.44% |
| Return on Capital Employed (ROCE) | -49.63% |
| Revenue Per Employee | $291,494 |
| Profits Per Employee | -$641,298 |
| Employee Count | 265 |
| Asset Turnover | 0.22 |
| Inventory Turnover | 6.96 |
Taxes
In the past 12 months, ADCT has paid $1.19 million in taxes.
| Income Tax | 1.19M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +19.31% in the last 52 weeks. The beta is 1.93, so ADCT's price volatility has been higher than the market average.
| Beta (5Y) | 1.93 |
| 52-Week Price Change | +19.31% |
| 50-Day Moving Average | 3.05 |
| 200-Day Moving Average | 2.20 |
| Relative Strength Index (RSI) | 56.95 |
| Average Volume (20 Days) | 625,707 |
Short Selling Information
The latest short interest is 5.68 million, so 5.05% of the outstanding shares have been sold short.
| Short Interest | 5.68M |
| Short Previous Month | 4.91M |
| Short % of Shares Out | 5.05% |
| Short % of Float | 6.16% |
| Short Ratio (days to cover) | 8.64 |
Income Statement
In the last 12 months, ADCT had revenue of $77.25 million and -$169.94 million in losses. Loss per share was -$1.58.
| Revenue | 77.25M |
| Gross Profit | -37.51M |
| Operating Income | -127.52M |
| Pretax Income | -170.29M |
| Net Income | -169.94M |
| EBITDA | -126.14M |
| EBIT | -127.52M |
| Loss Per Share | -$1.58 |
Full Income StatementBalance Sheet
The company has $264.56 million in cash and $450.77 million in debt, giving a net cash position of -$186.21 million or -$1.66 per share.
| Cash & Cash Equivalents | 264.56M |
| Total Debt | 450.77M |
| Net Cash | -186.21M |
| Net Cash Per Share | -$1.66 |
| Equity (Book Value) | -199.18M |
| Book Value Per Share | -1.77 |
| Working Capital | 254.16M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$127.32 million and capital expenditures -$570,000, giving a free cash flow of -$127.89 million.
| Operating Cash Flow | -127.32M |
| Capital Expenditures | -570,000 |
| Free Cash Flow | -127.89M |
| FCF Per Share | -$1.14 |
Full Cash Flow StatementMargins
Gross margin is -48.55%, with operating and profit margins of -165.08% and -220.00%.
| Gross Margin | -48.55% |
| Operating Margin | -165.08% |
| Pretax Margin | -218.47% |
| Profit Margin | -220.00% |
| EBITDA Margin | -163.30% |
| EBIT Margin | -165.08% |
| FCF Margin | n/a |
Dividends & Yields
ADCT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -25.84% |
| Shareholder Yield | -25.84% |
| Earnings Yield | -48.89% |
| FCF Yield | -36.79% |
Analyst Forecast
The average price target for ADCT is $7.80, which is 152.43% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $7.80 |
| Price Target Difference | 152.43% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | 35.22% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ADCT has an Altman Z-Score of -6.77 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -6.77 |
| Piotroski F-Score | 2 |